| Interleukine | Receptor | Cell source | Cell Target | Cardiovascular Impact |
| IL-1α,β | Type I IL-1r, Type II IL-1r | Monocytes/macrophage, fibroblast, endothelial cells, B cells, epithelial cells including thymic epithelium. | All cells | HTA [52, 58], ATS [53, 54, 60], IL-1β polymorphism and HTA [61–64, 66, 67], ST [73] | IL-4 | IL-4 α, common γ | Mast cells, T cells, basophils. | Endothelial cells, T cells, B cells fibroblast, NK-cells, monocytes, macrophages | Anti-inflammatory action on T cells [161] | IL-6 | IL-6r, gp130 | fibroblast, endothelial, Monocytes/macrophages, most epithelial cells including thymic epithelium. | Hepatocytes, macrophages, monocytes, T cells, B cells, epithelial cells | HTA [40, 82, 85, 88], ATS [106], IM [30], CHD [112, 113, 125], AF [126], CH [90], LVD [91], HTP [103, 105, 106], ST [119, 120] | IL-10 | IL-10r | T cells, B cells, monocytes macrophages, keratinocytes, mast cells | T cells, B cells, NK cells, mast cells, monocytes macrophages | Anti-inflammatory action on T cells [120, 156, 157] | IL-17 | IL-17r | CD4+ T cells | Endothelium, epithelium, fibroblast, macrophages | HTA [11], ATS [12, 131], IM and UA [135], CHF [137] | IL-23 | IL-12Rb1/IL23R | Macrophages, other cell types | T cells | ATS [12, 131] |
|
|